# Gong Hongjia

> Gong Hongjia is a angel investor at Hikvision Digital Technology backing Biotechnology. See 11 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Hikvision Digital Technology](https://shizune.co/investors/profile/hikvision-digital-technology)
- Total investments: 11
- Last investment: Jun 2026
- Lead investor: 64%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/gong-hongjia-025a05168

Gong Hongjia is a angel investor at Hikvision Digital Technology focused on Biotechnology and Medical. Gong Hongjia is the the founder of Jiadao Capital.

## Round sizes

| Stage | Round size |
| --- | --- |
| Angel | $1.4M–$14M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 4 | 36% |
| Medical | 3 | 27% |
| Life Science | 2 | 18% |
| Pharmaceutical | 2 | 18% |
| Audio | 1 | 9% |

17 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Angel | 4 | 36% |
| Seed | 2 | 18% |
| Series B | 1 | 9% |
| Series C | 1 | 9% |
| Corporate Round | 1 | 9% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Snow Origin | Snow Origin is a Beijing deep-tech company specializing in neural interfaces and surface EMG (sEMG) interaction. They build BCI peripheral hardware to deliver natural, stable human-computer interaction for next-generation AR/VR headsets and smart devices. |  | Angel | Jun 23, 2026 |  |
| Jiansheng Medicine | Jianersheng Pharmaceutical is a manufacturer of heavy metal detoxification drugs. It company is primarily involved in the research, development, and sale of special heavy metal detoxification drugs, such as special heavy metal detoxifiers and heavy metal diagnostic rapid detection kits. | $14M | Series B | Nov 03, 2025 |  |
| Meyer FSMP Hong Kong | Meyer FSMP Hong Kong leads the research and development and practical exploration of the oncology special medical food industry.With the support of Hong Kong Meiya Pharmaceutical Factory with nearly 50 years of pharmaceutical history, and with the cooperation of the Chinese mainland oncology product promotion team with 30 years of successfulexperience, Meyer FSMP has entered the special medical food industry across the board, leading the development of domestic nutrition therapy, and is committed to becoming a practitioner of the first-line treatment of tumor nutrition. |  | Corporate Round | Oct 24, 2025 |  |
| Lead Health | Lead Health is a hard technology startup company that transforms scientific and technological achievements of the academician team. It independently develops life science instruments and biopharmaceutical equipment and has independent intellectual property rights. |  | Seed | May 22, 2025 |  |
| Lead Health | Lead Health is a hard technology startup company that transforms scientific and technological achievements of the academician team. It independently develops life science instruments and biopharmaceutical equipment and has independent intellectual property rights. | $13.9M | Angel | May 22, 2025 |  |
| Rongxiu Shengsheng | Rongxiu Shengsheng specializes in industrial transformation and development of herbal plant essential oils for medicinal and cosmetic use. | $1.4M | Angel | Apr 11, 2025 |  |
| CapitalBio Pharma | CapitalBio Pharma is a biotechnology company that specializes in innovative medicines to empower precise diagnosis and treatment. It is a subsidiary of CapitalBio Corporation. | $5.6M | Angel | Jan 04, 2024 |  |
| POROSVOC | POROSVOC is an audio processing technology company that offers chip-level core services for intelligent voice enhancement and intelligent voice interaction solutions for financial equipment, communication equipment, robots, smart home products, small household appliances, and other industries. |  | Angel | Aug 02, 2023 |  |
| KMAX | KMAX specializes in AR and VR content research and development. It has independently developed core technologies such as real-time 3D modeling, 3D generalized cloud connection, cloud VR resource rendering, and an editing engine. |  | Seed | Nov 08, 2022 |  |
| Dao Bio-Link | Dao Biolink is an information system integration and Internet of Things technology service provider. | $14.9M | Series A | May 25, 2022 |  |

10 of 11 investments shown.

## Co-investors
- [CAS Star](https://shizune.co/investors/profile/cas-star) — VC Fund, 2 deals together
- [Gongshan Capital](https://shizune.co/investors/profile/gongshan-capital) — VC Fund, 2 deals together
- [Insight Capital](https://shizune.co/investors/profile/insight-capital-ccfa) — VC Fund, 2 deals together
- [Jiuzhou Xinnuo](https://shizune.co/investors/profile/jiuzhou-xinnuo) — VC Fund, 2 deals together
- [Juke Emerging Industry Venture Capital](https://shizune.co/investors/profile/juke-emerging-industry-venture-capital) — VC Fund, 2 deals together
- [Qiji Investment](https://shizune.co/investors/profile/qiji-investment) — VC Fund, 2 deals together

## About Hikvision Digital Technology

VC Fund · Hangzhou, China

Hikvision is the world's largest supplier of video surveillance products and solutions. The company specializes in video surveillance technology, as well as designing and manufacturing a full-line of innovative CCTV and video surveillance products. The product line ranges from cameras and DVRs to video management software. Since its inceptionin 2001, Hikvision has quickly achieved a leading worldwide market position in the security industry. Hikvision possess the world's largest R&D team and state-of-art manufacturing facilities; both allow Hikvision’s customers the benefit of world-class products that are designed with cutting-edge technology. As further commitment to its customers, Hikvision annually reinvests 8% of its revenue into R&D for continued product innovation and improvement.Hikvision operates over 30 domestic branches in China and 16 overseas regional subsidiaries all over the world to achieve a truly global presence. Hikvision is now publicly listed on the Shenzhen Stock Exchange.

5 contacts available at Hikvision Digital Technology.

| Name | Title | Profile |
| --- | --- | --- |
| Zhiping Zhou | Vice President | https://shizune.co/investors/profile/zhiping-zhou |
| Anthony DeStefano | Senior Business Development Manager | https://shizune.co/investors/profile/anthony-destefano |
| Eric Chen | General Manager, North America | https://shizune.co/investors/profile/eric-chen-7 |
| Gong Hongjia | Founder | https://shizune.co/investors/profile/gong-hongjia-a33c |
| Hu Yangzhong | Chief Executive Officer | https://shizune.co/investors/profile/hu-yangzhong |

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [LVX Ventures](https://shizune.co/investors/profile/letsventure) — VC Fund
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund
- [IAN Group](https://shizune.co/investors/profile/indian-angel-network) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [All Angel Investors in China](https://shizune.co/investors/angel-investors-china)
- [Software Angel Investors in China](https://shizune.co/investors/software-angel-investors-china)
- [SaaS Angel Investors in China](https://shizune.co/investors/saas-angel-investors-china)
- [Life Science Investors in China](https://shizune.co/investors/life-science-investors-china)
- [Biotechnology Angel Investors in Asia](https://shizune.co/investors/biotechnology-angel-investors-asia)
- [Biotechnology Angel Investors in China](https://shizune.co/investors/biotechnology-angel-investors-china)

## FAQ

### What does Gong Hongjia invest in?

Gong Hongjia invests primarily in Biotechnology, Medical and Life Science startups, most often at Angel and Seed stage. Most of the 11 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Gong Hongjia's check size?

Gong Hongjia typically joins rounds of $1.4M–$14M at Angel. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Gong Hongjia participates in.

### When did Gong Hongjia last invest?

The most recent investment recorded for Gong Hongjia closed in Jun 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co